Headache Classification Subcommittee of the International Headache Society.The International Classification of Headache Disorders (II). Cephalalgia2004;24(Suppl 1):1–160.
2.
LeonardiMSteinerTJScherAILiptonRBThe global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF). J Headache and Pain2005;6:429–40.
3.
SteinerTJScherAIStewartWFKolodnerKLibermanJLiptonRBThe prevalence and disability burden of adult migraine in England and their relationship to age, gender and ethnicity. Cephalalgia2003;23(7):519–27.
4.
LiptonRBStewartWFThe epidemiology of migraine. Eur Neurol1994;34(S2):6–11.
5.
ScherAIStewartWFLibermanJ.Prevalence of frequent headache in a population sample. Headache1998;38(7):497–506.
6.
CastilloJMuñozPGuiteraVPascualJ.Epidemiology of chronic daily headache in the general population. Headache1999;39(3):190–6.
7.
WangSJFuhJLLuSRLiuCYHsuLCChronic daily headache in Chinese elderly: prevalence, risk factors and biannual follow-up. Neurology2000;54(2):3l4–9.
8.
LuS-RFuhJ-LChenW-TJuangK-DWangS-JChronic daily headache in Tapei, Taiwan: Prevalence, follow-up and outcome predictors. Cephalalgia2001;21(10):980–6.
9.
BlauNJAdult migraine: The patient observed. In: BlauNJ, ed. Migraine: clinical, therapeutic, conceptual and research aspects. London: Chapman and Hall1987:3–30.
10.
RussellMBAnderssonPGIseliusL.Cluster headache is an inherited disorder in some families. Headache1996;36(10):608–12.
11.
GiffinNJRuggieroLLiptonRBSilbersteinSDTvedskovJFPremonitory symptoms in migraine: An electronic diary study. Neurology2003;60(6):935–40.
12.
RasmussenBKJensenROlesenJ.A population-based analysis of the diagnostic criteria of the International Headache Society. Cephalalgia1991;11(3):129–34.
13.
KelmanL.Migraine pain location: A tertiary care study of 1283 migraineurs. Headache2005;45(8):1038–47.
14.
ChakravatyAMukhurjeeARoyD.Migraine pain location in adult patients from eastern India. Annals Indian Acad of Neurol2008;11(2):98–102.
15.
KaubeHKeayKAHoskinKLBandlerRGoadsbyPJExpression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat. Brain Res1993;629(1):95–102.
16.
BuschVJakobWJuergensTSchulte-MattlerWKaubeHMayA.Occipital nerve blockade in chronic cluster headache patients and functional connectivity between trigeminal and occipital nerves. Cephalalgia2007;27(11):1206–14.
17.
AfridiSKShieldsKGBholaRGoadsbyPJGreater occipital nerve injections in primary headache syndromes — prolonged effects from a single injection. Pain2006;122(1–2):126–9.
18.
SaperJRDodickDWSilbersteinSDMcCarvilleSSunMOccipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia2010;31(3):271–85.
19.
CouchJRDiamondS.Status migrainosus: Causative and therapeutic aspects. Headache. 1983;23(3):94–101.
20.
CelentanoDPStewartWFLinetMSThe relationship of headache symptoms with severity and duration of attacks. J Clin Epidem1990;43(9):983–4.
21.
PrenskyALMigraine in children. In: BlauNJ, ed. Migraine: Clinical, therapeutic, conceptual and research aspects. London: Chapman and Hall1987:31–54.
22.
BlauNJResolution of migraine attacks: sleep and recovery phase. J Neurol Neurosurg Psych1982;45(3):223–6.
23.
BahraAMayAGoadsbyPJCluster headache: A prospective clinical study with diagnostic implications. Neurology2002;58(3):354–61.
24.
PeresMFPSiowHCRozenTDHemicrania continua with aura. Cephalagia2002;22(3):246–8.
RussellMBOlesenJ.A nosographic analysis of the migraine aura in a general population. Brain1996;119(2):335–61.
27.
EriksenMKThomsenLLAndersenINazimFOlesenJ.Clinical characteristics of 362 patients with familial migraine with aura. Cephalalgia2004;24(7):564–75.
28.
BlauNJClassic migraine: symptoms between visual aura and headache onset. Lancet1992;340(8815):355–6.
29.
ThomsenLLEriksenMKRoemerIAndersenAROlesenJRussellMBA population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain2002;125:1379–91.
30.
LiptonRBCadyRKStewartWFWilksPHallC.Diagnostic lessons from the Spectrum Study. Neurology2002;58(Suppl 6):S27–S31.
31.
AshinaMBendtsenLJensenRSchifterSJansen-OlesenIOlesenJ.Plasma levels of calcitonin gene-related peptide in chronic tension-type headache. Neurology2000;55(9):1335–9.
32.
CadyRKGuttermanDSaiersJABeachMEResponsiveness of non-IHS migraine and tension-type headache. Cephalalgia1997;17(5):588–90.
33.
WolffHG, ed. Headache and other head pain. New York: Oxford University Press1963.
34.
MartinsIPBaetaEPaivaTCampoTGomesL. Headaches during intracranial endovascular procedures: a possible model of vascular headache. Headache1993;33(5):227–33.
35.
GrahamJRWolffHGMechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psych1938;39(4Orofacial Pain: Part Two):737–63.
36.
DrummondPDLanceJWNeurovascular disturbances in headache patients. Clin Exp Neurol1984;20:93–9.
37.
RahmannAWieneckeTHansenJMFahrenkrugJOlesenJAshinaM.Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia2008;28(3):226–36.
38.
MatharuMSGoadbsyPJPersistence of attacks of cluster headache after trigeminal root section. Brain2002;125(5):976–84.
39.
HumphreyPPFeniukW.Mode of action of the anti-migraine drug sumatriptan. Trends Pharmacol Sci1991;12(12):444–6.
40.
HoskinKLKaubeHGoadsbyPJCentral activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study. Brain1996;119(Pt 1):249–56.
41.
BartschTKnightYEGoadsbyPJActivation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception. Ann Neurol2004;56(3):371–81.
42.
WeillerCMayALimmrothVJuptnerMKaubeHBrain stem activation in spontaneous human migraine attacks. Nat Med1995;1(7):658–60.
43.
MayABahraABuchelCFrackowiakRSJGoadsbyPJHypothalamic activation in cluster headache attacks. Lancet1998;352(9124):275–8.
44.
van den MaagdenbergAMHaanJTerwindtGMFerrariMDMigraine: gene mutations and functional consequences. Curr Opin Neurol2007;20(3):299–305.
45.
LafrenièreRGCaderMZPoulinJFAndres-EnguixISimoneauMGuptaNA dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Nat Med. 2010;16(10):1157–60.
46.
RobbinsL.Precipitating factors in migraine: A restrospective review of 494 patients. Headache1994;34(4Orofacial Pain: Part Two):214–6.
47.
Van den BerghVAmeryWKWaelkensJ.Trigger factors in migraine: A study conducted by the Belgian Migraine Society. Headache1987;27(4Orofacial Pain: Part Two):191–6.
48.
TurnerLCMolgaardCAGardnerCHRothcockJFStangPEMigraine trigger factors in a non-clinical Mexican-American population in San Diego county: implications for etiology. Cephalalgia1995;15(6):523–30.
49.
McQueenJLoblayARA controlled trial of dietary modification in migraine. In: RoseFC, ed. New Advances in Headache Research. London: Smith Gordon1989.
50.
LimmrothVKatsaravaZFritscheGPrzywaraSDienerHCFeatures of medication overuse headache following overuse of different acute headache drugs. Neurology2002;59(7):1011–4.
51.
SilvermanKEvansSMStrainECWithdrawal syndrome after double-blind cessation of caffeine consumption. New Eng J Med1992;327(16):1109.
EversS AJFreseAGoadsbyPJLindeMMayASandorPSEFNS guideline on the drug treatment of migraine - report of an EFNS task force. Eur J Neurol2006;13(6):560–72.
54.
FerrariMDGoadbsyPJRoonKILiptonRBTriptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalagia2002;22:633–58.
55.
BrandesJLKudrowDStarkSRO'CarrollCPAdelmanJUSumatriptan-naproxen for acute treatment of migraine: a randomized trial. JAMA2007;297(13):1443–54.
56.
The Subcutaneous Sumatriptan International Study Group.Treatment of acute migraine with sumatriptan. New Eng J Med1991;325(5):316–21.
57.
Tfelt-HansenPRolanP.Non-steroidal anti-inflammatory drugs in the acute treatment of migraines. In: OlesenJGoadbsyPJRamadanNM eds. The headaches. 3rd ed.Philadelphia: Lippincott Williams and Wilkins2006.
58.
LiptonRBStewartWFStoneAMStratified care vs step care startegies for migraine: results of the Disability in Strategies of Care (DISC) Study. JAMA2000;284(20):754–63.
59.
ValadeD.Early treatment of acute migraine: new evidence of benefits. Cephalalgia2009;Suppl 3.
60.
LindeMMelbergADahlofC.Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack. Cephalalgia2006;26(2):113–21.
61.
SaperJRErgotamine dependancy - a review. Headache1987;27(8):435–8.
62.
BatesDAshfordEDawsonREnsinkF-BMGilhusNESubcutaneous sumatriptan during migraine aura. Neurology1994;44(9):1587–92.
63.
ThomsenLLDixonRLassenLHGiboensMLangemarkM311C90 (Zolmitriptan), a novel centrally and peripheral acting oral 5-hydroxytryptamine-1D agonist: a comparison of its absorption during a migraine attacks and in a migraine-free period. Cephalalgia1996;16(4Orofacial Pain: Part Two):270–5.
64.
TokolaRAKangasniemiPNeuvonenPJTokolaO.Tolfenamic acid, metoclopramide, caffeine and their combinations in the treatment of migraine attacks. Cephalalgia1983;4(4Orofacial Pain: Part Two):253–63.
65.
MacGregorEAWilkinsonMBancroftK.Domperidone plus paracetamol in the treatment of migraine. Cephalalgia1993;13(2):124–7.
66.
BahraAWalshMMenonSGoadsbyPJDoes chronic daily headache arise de novo in association with regular analgesic use?Headache2003;43(3):179–90.
67.
PaemeleireKBahraAEversSMatharuMSGoadbsyPJMedication-overuse headache in patients with cluster headache. Neurology2006;67(1):109–13.
68.
DienerH-CDichgansJScholzEGeiselhartSGerberW-GBilleA.Analgesic-induced chronic headache: long term results of withdrawal therapy. J Neurol1989;236(1):9–14.
69.
ZeebergPOlesenJJensenR.Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia2006;26(10):1192–8.
70.
EversSMarziniakM.Clinical features, pathophysiology and treatment of medication-overuse headache. Lancet Neurol2010; (4Orofacial Pain: Part Two):391–401.
71.
BigalMELiptonRBModifiable risk factors for migraine progression (or for chronic daily headaches) - clinical lessons. Headache2006;46(Suppl 3):S144–6.
72.
RadatFSwendsenJ.Psychiatric comorbidity in migraine: a review. Cephalalgia2004;25(3):165–78.
73.
AlterMDaubeJRFranklinGFrishbergBMGoldsteinMLPractice parameter: The utility of neuroimaging in the evaluation of headache in patients with normal neurologic examinations (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology1994;44(7):1353–4.
74.
WeissHDSternBJGoldbergJ.Post-traumatic migraine: chronic migraine precipitated by minor head or neck trauma. Headache1991;31(7):451–6.
75.
RosenbergJHSilbersteinSDThe headache of SAH responds to sumatriptan. Headache2005;45(5):597–8.
76.
VestergaardKAndersenGNielsenMIJensenTSHeadache in stroke. Stroke1993;24(11):1621–4.
77.
SlooterAJRamosLMKappelleLJMigraine-like headache as the presenting symptom of cerebral venous sinus thrombosis. J Neurol2002;249(6):775–6.
78.
LamplCYazdiKBuzathAKlinglerD.Migraine-like headache in bacterial meningitis. Cephalalgia2000;20(8):738–9.
79.
ScelsaSNLiptonRBSanderHHerskovitzS.Headache characteristics in hospitalized patients with Lyme disease. Headache1995;35(3):125–30.
